Fumie Noguchi, Po‐sung Chu, Nobuhito Taniki, Aya Yoshida, Rei Morikawa, Akihiro Yamaguchi, Akihiko Ikura, Karin Yamataka, Hitomi Hoshi, Shingo Usui, Hirotoshi Ebinuma, Hidetsugu Saito, Takanori Kanai, Nobuhiro Nakamoto – 17 October 2020
Brendan Harney, Roisin McColl, Alisa Pedrana, Eleanor Morrison, Joseph Doyle, Margaret Hellard, Peter Higgs – 16 October 2020
Ben L. Da, Tatyana Kushner, Maan El Halabi, Pavan Paka, Mian Khalid, Angad Uberoi, Brian T. Lee, Ponni V. Perumalswami, Stephanie M. Rutledge, Thomas D. Schiano, Scott L. Friedman, Behnam Saberi – 16 October 2020 – Liver injury is commonly seen in coronavirus disease 2019 (COVID‐19); however, the mechanism behind liver injury, particularly in patients with severe and critical COVID‐19, remains unclear, and the clinical course is poorly described.
DESCRIPTION There is currently an anticipated shortage of trained providers capable of diagnosing and treating different liver diseases. As a result of this increased demand and limited specialists in the field, more and more front-line providers are faced with these patients and do not have the experience or resources that will allow them to manage them appropriately.
Xue‐Jing Li, Qing‐Lan Li, Lin‐Gao Ju, Chen Zhao, Lan‐Shen Zhao, Jia‐Wen Du, Yan Wang, Ling Zheng, Bao‐Liang Song, Lian‐Yun Li, Li Li, Min Wu – 15 October 2020
Treatment failure. Incomplete response. Treatment intolerance. Management of autoimmune hepatitis can be extremely challenging when first-line therapy is inadequate. Join us for a discussion of alternative treatment options for autoimmune hepatitis and a review of their efficacy. Learn about updates to the treatment paradigm from the new 2019 guidelines!
14 October 2020
14 October 2020
14 October 2020
14 October 2020